miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

The Download: The Pentagon’s new AI plans, and next-gen nuclear reactors

View original at technologyreview.com
MIT Technology Review - Ai Research Title: The Download: The Pentagon’s new AI plans, and next-gen nuclear reactors Date: 2026-03-18 12:38 Source: https://www.technologyreview.com/2026/03/18/1134371/the-download-the-pentagons-new-ai-plans-and-next-gen-nuclear-reactors/ <p><em>This is today’s edition of </em><a href="ht…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Training on classified data would embed sensitive intelligence—like surveillance reports or battlefield assessments—into the models themselves

    60% confidence
  • An approaching wave of new nuclear reactors could introduce fresh challenges to nuclear waste management

    60% confidence
  • The Pentagon wants to mass-produce the Lucas kamikaze drones it used to strike Iran

    60% confidence
  • US officials say Anthropic can't be trusted with warfighting systems

    60% confidence
  • Uncrewed narco subs could move more cocaine over longer distances without putting human smugglers at risk of capture

    60% confidence
  • The Pentagon plans to set up secure environments for generative AI companies to train military-specific versions of their models on classified data

    60% confidence
  • Allowing AI models to train on and learn from classified data is a major new development that presents unique security risks

    60% confidence
  • OpenClaw is now the largest, most popular, the most successful open-sourced project in the history of humanity and is definitely the next ChatGPT

    60% confidence
  • AI models like Anthropic's Claude are already used to answer questions in classified settings, including for analyzing targets in Iran

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com